Fiocruz signs deal for radiopharma development in Brazil

In partnership with the University of Coimbra, Portugal, Brazil’s Fiocruz has signed an agreement for the technological development of radiopharmaceuticals and the future health registration of products in Brazil.

The collaboration takes place through the Institute of Drug Technology (Farmanguinhos/Fiocruz) and was made official on July 19 in Coimbra. On the occasion, two other agreements were also signed: one in the field of education and another for the health registration of Farmanguinhos products in Portugal.

“I am sure that our Unified Health System (SUS, in the Portuguese acronym) will benefit from the technological development of radiopharmaceuticals, and that we can contribute to the Portuguese health system by supplying medicines produced by Fiocruz and registered in Portugal. The agreements being signed today also had the crucial support of our Anvisa, which is committed to expanding access to available treatments for the population of both countries," said Fiocruz president, Mario Moreira.